OIG report says Part D plans aren’t accurately tracking out of pocket costs as required by law

In a recent study, the Office of Inspector General (OIG) for the Department of Health and Human Services found that Medicare drug plans have not met all requirements for tracking out-of-pocket spending by beneficiaries in the Medicare Part D prescription drug program. Accurate tracking of beneficiaries’ true out-of-pocket (TrOOP) costs is critical to ensuring appropriate cost sharing under the Part D
program.

See the press release  or the full report.